Pharma’s Almanac Features AVM0703

Combating cancer and other diseases with supercharged natural killer T-cells, mobilized by a novel formulation of Dexamethasone – Theresa Deisher, Ph.D., CEO and Founder of AVM Biotechnology, spoke with Pharma’s Almanac Managing Editor Emilie Branch.